Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colorectal Neoplasms 49Rectal Neoplasms 26Colonic Neoplasms 23Pancreatic Neoplasms 19Neoplasm Metastasis 17Neoplasms 13Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Esophageal Neoplasms 6Osteosarcoma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Burkitt Lymphoma 5Myelodysplastic Syndromes 4Gallbladder Neoplasms 4Adenocarcinoma Of Esophagus 4Triple Negative Breast Neoplasms 3Sarcoma 3Melanoma 3Lymphoma 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Rituximab 2pembrolizumab 1merphos 1avelumab 1apatinib 1Zidovudine 1Valganciclovir 1Tegafur 1Mitomycin 1Methotrexate 1Leucovorin 1Hydroxyurea 1Epirubicin 1Doxorubicin 1Cisplatin 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Epstein-Barr Virus Infections × Leucovorin × Clear all
NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

University of Miami

Phase 2 Terminated
6 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡